Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1986 1
1987 1
1988 1
1989 1
1990 2
1991 2
1992 1
1993 2
1994 5
1995 2
1996 8
1997 6
1998 3
1999 5
2000 9
2001 5
2002 7
2003 6
2004 8
2005 18
2006 29
2007 35
2008 43
2009 39
2010 35
2011 34
2012 38
2013 42
2014 39
2015 37
2016 45
2017 40
2018 32
2019 47
2020 44
2021 44
2022 12
2023 20

Text availability

Article attribute

Article type

Publication date

Search Results

652 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic phenotype of bladder cancer.
Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R, Tortora G, Lopez-Beltran A, Cheng L, Montironi R. Massari F, et al. Among authors: lopez beltran a. Cancer Treat Rev. 2016 Apr;45:46-57. doi: 10.1016/j.ctrv.2016.03.005. Epub 2016 Mar 8. Cancer Treat Rev. 2016. PMID: 26975021 Free article. Review.
News in the classification of WHO 2022 bladder tumors.
Raspollini MR, Comperat EM, Lopez-Beltran A, Montironi R, Cimadamore A, Tsuzuki T, Netto GJ. Raspollini MR, et al. Among authors: lopez beltran a. Pathologica. 2022 Feb;115(1):32-40. doi: 10.32074/1591-951X-838. Epub 2023 Jan 25. Pathologica. 2022. PMID: 36704871 Free PMC article. Review.
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer.
Lopez-Beltran A, Cimadamore A, Blanca A, Massari F, Vau N, Scarpelli M, Cheng L, Montironi R. Lopez-Beltran A, et al. Cancers (Basel). 2021 Jan 3;13(1):131. doi: 10.3390/cancers13010131. Cancers (Basel). 2021. PMID: 33401585 Free PMC article. Review.
Epigenetic modulations and lineage plasticity in advanced prostate cancer.
Ge R, Wang Z, Montironi R, Jiang Z, Cheng M, Santoni M, Huang K, Massari F, Lu X, Cimadamore A, Lopez-Beltran A, Cheng L. Ge R, et al. Among authors: lopez beltran a. Ann Oncol. 2020 Apr;31(4):470-479. doi: 10.1016/j.annonc.2020.02.002. Epub 2020 Feb 13. Ann Oncol. 2020. PMID: 32139297 Free article. Review.
Staging of bladder cancer.
Magers MJ, Lopez-Beltran A, Montironi R, Williamson SR, Kaimakliotis HZ, Cheng L. Magers MJ, et al. Among authors: lopez beltran a. Histopathology. 2019 Jan;74(1):112-134. doi: 10.1111/his.13734. Histopathology. 2019. PMID: 30565300 Review.
Molecular pathology of urothelial carcinoma.
Lopez-Beltran A, Cimadamore A, Montironi R, Cheng L. Lopez-Beltran A, et al. Hum Pathol. 2021 Jul;113:67-83. doi: 10.1016/j.humpath.2021.04.001. Epub 2021 Apr 19. Hum Pathol. 2021. PMID: 33887300 Review.
Editorial: Emerging Biomarkers in Genitourinary Tumors.
Montironi R, Lopez-Beltran A, Cheng L. Montironi R, et al. Among authors: lopez beltran a. Curr Drug Metab. 2017;18(8):690-691. doi: 10.2174/138920021808171016103101. Curr Drug Metab. 2017. PMID: 29113591 No abstract available.
The Identification of Immunological Biomarkers in Kidney Cancers.
Lopez-Beltran A, Henriques V, Cimadamore A, Santoni M, Cheng L, Gevaert T, Blanca A, Massari F, Scarpelli M, Montironi R. Lopez-Beltran A, et al. Front Oncol. 2018 Nov 2;8:456. doi: 10.3389/fonc.2018.00456. eCollection 2018. Front Oncol. 2018. PMID: 30450335 Free PMC article. Review.
Molecular diagnostics in uro-oncology.
Montironi R, Cheng L, Cimadamore A, Lopez-Beltran A. Montironi R, et al. Among authors: lopez beltran a. Expert Rev Mol Diagn. 2020 Feb;20(2):117-121. doi: 10.1080/14737159.2020.1715799. Epub 2020 Jan 29. Expert Rev Mol Diagn. 2020. PMID: 31933387 No abstract available.
652 results